Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Feb 11;10(2):e0113367.
doi: 10.1371/journal.pone.0113367. eCollection 2015.

Preventing loss of independence through exercise (PLIÉ): a pilot clinical trial in older adults with dementia

Affiliations
Clinical Trial

Preventing loss of independence through exercise (PLIÉ): a pilot clinical trial in older adults with dementia

Deborah E Barnes et al. PLoS One. .

Abstract

Background: Current dementia medications have small effect sizes, many adverse effects and do not change the disease course. Therefore, it is critically important to study alternative treatment strategies. The goal of this study was to pilot-test a novel, integrative group exercise program for individuals with mild-to-moderate dementia called Preventing Loss of Independence through Exercise (PLIÉ), which focuses on training procedural memory for basic functional movements (e.g., sit-to-stand) while increasing mindful body awareness and facilitating social connection.

Methods: We performed a 36-week cross-over pilot clinical trial to compare PLIÉ with usual care (UC) at an adult day program for individuals with dementia in San Francisco, CA. Assessments of physical performance, cognitive function, physical function, dementia-related behaviors, quality of life and caregiver burden were performed by blinded assessors at baseline, 18 weeks (cross-over) and 36 weeks. Our primary outcomes were effect sizes based on between-group comparisons of change from baseline to 18 weeks; secondary outcomes were within-group comparisons of change before and after cross-over.

Results: Twelve individuals enrolled (7 PLIÉ, 5 UC) and 2 withdrew (1 PLIÉ, 18 weeks; 1 UC, 36 weeks). Participants were 82% women (mean age, 84 ± 4 years); caregivers were 82% daughters (mean age, 56 ± 13 years). Effect sizes were not statistically significant but suggested potentially clinically meaningful (≥ 0.25 SDs) improvement with PLIÉ versus UC for physical performance (Cohen's D: 0.34 SDs), cognitive function (0.76 SDs) and quality of life (0.83 SDs) as well as for caregiver measures of participant's quality of life (0.33 SDs) and caregiver burden (0.49 SDs). Results were similar when within-group comparisons were made before and after cross-over.

Conclusions: PLIÉ is a novel, integrative exercise program that shows promise for improving physical function, cognitive function, quality of life and caregiver burden in individuals with mild-to-moderate dementia. Larger randomized, controlled trials are warranted.

Trial registration: ClinicalTrials.gov NCT01371214.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow Diagram of Study Participants.
A total of 22 participant (PT)/caregiver (CG) dyads were assessed for eligibility, of whom 10 were excluded and 12 were enrolled and allocated to Group 1 (n = 7) or Group 2 (n = 5). Group 1 participated in the Preventing Loss of Independence through Exercise (PLIÉ) program while Group 2 participated in Usual Care activities from weeks 1 to 18. The groups then crossed over, and Group 1 returned to Usual Care activities while Group 2 participated in PLIÉ from weeks 19 to 36. Assessments were performed at baseline, 18 weeks and 36 weeks. One participant withdrew from Group 1 prior to the 18-week assessment and one participant withdrew from Group 2 prior to the 36-week assessment. In addition, one CG in Group 2 did not complete the 18- or 36-week assessments.

References

    1. Thies W, Bleiler L, Alzheimer's Association (2013) 2013 Alzheimer's disease facts and figures. Alzheimers Dement 9: 208–245. 10.1016/j.jalz.2013.02.003 - DOI - PubMed
    1. Acosta D, Wortmann M (2009) World Alzheimer Report. Alzheimer's Disease International;
    1. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM (2013) Monetary costs of dementia in the United States. N Engl J Med 368: 1326–1334. 10.1056/NEJMsa1204629 - DOI - PMC - PubMed
    1. Hansen RA, Gartlehner G, Lohr KN, Kaufer DI (2007) Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis. Drugs Aging 24: 155–167. - PubMed
    1. Rockwood K (2004) Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75: 677–685. - PMC - PubMed

Publication types

Associated data